GC Rieber VivoMega launches omega-3 softgel sampling program ahead of SupplySide West 2021
Targeting North American customers, the VivoMega softgel sampling program will ship a full month’s worth of softgels along with a label and look “that portrays the quality that VivoMega promises.”
Photo from GC Rieber VivoMega
Omega-3 concentrates supplier GC Rieber VivoMega (Norway) has launched a new softgel sampling program ahead of the upcoming SupplySide West trade show in Las Vegas. Targeting North American customers, the VivoMega softgel sampling program will ship a full month’s worth of softgels along with a label and look “that portrays the quality that VivoMega promises.”
According to GC Rieber VivoMega, this program showcases how its omega-3 ingredients can address different health benefits, including heart, immune, sports, brain, eye, maternity, bone, and joint health.
VivoMega ingredients are said to offer superior taste and smell, with minimal sensory experience and a reduction in fishy aftertaste, primarily because they boast lower oxidation levels. The company says its oxidation values today are lower than those of widely used global standards, including 75% lower than IFOS 5-star and 80% lower than the GOED monograph. The ingredients also offer eco-friendly supply and production and high EPA/DHA content and bioavailability.
Samples from the program will also be available from GC Rieber VivoMega at the Barrington Nutritionals booth (#3528) at SupplySide West.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
